Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension

This publication has 22 references indexed in Scilit:

• Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
  Circulation, 1990
• Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension
  The American Journal of Cardiology, 1989
• Selective dopamine-1 agonist therapy in severe hypertension: Effects of intravenous fenoldopam
  Journal of the American College of Cardiology, 1988
• The Effect of Selective Dopamine-1 Receptor Stimulation on Renal and Adrenal Function in Man*
  Journal of Clinical Endocrinology & Metabolism, 1988
• Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1‐receptor agonist, in hypertensive patients.
  British Journal of Clinical Pharmacology, 1988
• Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.
  Circulation, 1987
• Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
  Journal of Clinical Investigation, 1984
• Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.
  Circulation, 1984
• Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin.
  Circulation, 1978
• Sodium Nitroprusside
  New England Journal of Medicine, 1975